DICER1 and breast carcinoma: Together with results acquired above, we hypothesized that the suppressive roles of miR-129 may be attributed to the active pathway of miR-129/ESR1/Let-7b in groups of stem-like cells in breast cancer, dependent on the existence of cyclin d1/DICER1.